{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:17:23Z","timestamp":1795130243657,"version":"4.10.3"},"reference-count":53,"publisher":"Association of Basic Medical Sciences of FBIH","issue":"5","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomol Biomed"],"abstract":"<jats:p>Pneumocystis jirovecii pneumonia (PCP), caused by fungal species named Pneumocystis jirovecii, is a frequent opportunistic infection in those with human immunodeficiency virus (HIV) infection. However, PCP has been documented in immunocompetent patients. This study aims to determine if P. jirovecii detection occurs in asthma patients following coronavirus disease 2019 (COVID-19) in a Jordanian cohort. Also, to evaluate a method of TaqMan quantitative polymerase chain reaction (qPCR) assay to detect P. jirovecii, from sputum samples. The nasopharyngeal swabs were used to detect SARS-CoV-2 and sputum samples were tested for P. jirovecii using real time qPCR assay. Beta-tubulin (BT) and Dihydrofolate reductase (DHFR) genes were the directed targets of P. jirovecii. The results showed that the mean qPCR efficiencies of BT and DHFR were 96.37% and 100.13%, respectively. Three out of 31 included patients (9.7%) had a positive P. jirovecii. All of the three patients had used oral corticosteroids (OCS) in the last two months due asthma exacerbation and were treated with OCS for COVID-19. This is the first study based in Jordan to demonstrate that P. jirovecii and COVID-19 can co-exist and that it is important to maintain a broad differential diagnosis, especially in immunocompromised patients. Chronic lung disease can be a risk factor for the P. jirovecii colonization possibly due to corticosteroid's immunosuppression.<\/jats:p>","DOI":"10.17305\/bjbms.2022.7335","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T18:43:31Z","timestamp":1652813011000},"page":"784-790","source":"Crossref","is-referenced-by-count":8,"title":["The first detection of Pneumocystis jirovecii in asthmatic patients post-COVID-19 in Jordan"],"prefix":"10.17305","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1324-7884","authenticated-orcid":false,"given":"Ahmad Riyad","family":"Alsayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wamidh","family":"Talib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al-Dulaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al Maqbali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6922","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"144719","doi-asserted-by":"crossref","unstructured":"Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19:We should be prepared. J Mycol Med. 2020;30(2):100971. doi:10.1016\/j.mycmed.2020.100971","DOI":"10.1016\/j.mycmed.2020.100971"},{"key":"144720","doi-asserted-by":"crossref","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 aHospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. doi:10.1001\/jama.2020.1585","DOI":"10.1001\/jama.2020.1585"},{"key":"144721","doi-asserted-by":"crossref","unstructured":"Zhou Y, Yang Q, Chi J, Dong B, Lv W, Shen L, et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019:A systematic review and meta-analysis. Int J Infect Dis. 2020;99:47-56. doi:10.1016\/j.ijid.2020.07.029","DOI":"10.1016\/j.ijid.2020.07.029"},{"key":"144722","doi-asserted-by":"crossref","unstructured":"Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069-76. doi:10.1007\/s42399-020-00363-4","DOI":"10.1007\/s42399-020-00363-4"},{"key":"144723","doi-asserted-by":"crossref","unstructured":"Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 apatients with COVID-19 in China:A nationwide analysis. Eur Respir J. 2020;55(5):2000547.","DOI":"10.1183\/13993003.01227-2020"},{"key":"144724","doi-asserted-by":"crossref","unstructured":"Joseph C, Togawa Y, Shindo N. Bacterial and viral infections associated with influenza. Influenza Other Respir Viruses. 2013;7(2):105-13. doi:10.1111\/irv.12089","DOI":"10.1111\/irv.12089"},{"key":"144725","doi-asserted-by":"crossref","unstructured":"Baddley JW. Covid-19 aassociated pulmonary aspergillosis:Do we have the capacity to improve outcomes?. Clin Infect Dis. 2021;74(1):92-4.","DOI":"10.1093\/cid\/ciab259"},{"key":"144726","doi-asserted-by":"crossref","unstructured":"Chong WH, Saha BK, Ramani A, Chopra A. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 apneumonia. Infection. 2021;49(4):591-605. doi:10.1007\/s15010-021-01602-z","DOI":"10.1007\/s15010-021-01602-z"},{"key":"144727","doi-asserted-by":"crossref","unstructured":"Chong WH, Neu KP. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA):A systematic review. J Hosp Infect. 2021;113:115-29. doi:10.1016\/j.jhin.2021.04.012","DOI":"10.1016\/j.jhin.2021.04.012"},{"key":"144728","doi-asserted-by":"crossref","unstructured":"Chong WH, Chieng H, Tiwari A, Beegle S, Feustel PJ, Ghalib S, et al. Incidence and risk factors for secondary pulmonary infections in patients hospitalized with coronavirus disease 2019 apneumonia. Am J Med Sci. 2022;363(6):476-83. doi:10.1016\/j.amjms.2021.04.007","DOI":"10.1016\/j.amjms.2021.04.007"},{"key":"144729","doi-asserted-by":"crossref","unstructured":"Chen X, Liao B, Cheng L, Peng X, Xu X, Li Y, et al. The microbial coinfection in COVID-19. Appl Microbiol Biotechnol. 2020;104(18):7777-85. doi:10.1007\/s00253-020-10814-6","DOI":"10.1007\/s00253-020-10814-6"},{"key":"144730","doi-asserted-by":"crossref","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis:The 2020 aECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21(6):e149-62. doi:10.1016\/s1473-3099(20)30847-1","DOI":"10.1016\/S1473-3099(20)30847-1"},{"key":"144731","doi-asserted-by":"crossref","unstructured":"Alanio A, Dellio S, Voicu S, Bretagne S, Metagned B. The presence of Pneumocystis jirovecii in critically ill patients with COVID-19. J Infect. 2021;82(4):84-123. doi:10.1016\/j.jinf.2020.10.034","DOI":"10.1016\/j.jinf.2020.10.034"},{"key":"144732","doi-asserted-by":"crossref","unstructured":"Coleman H, Snell LB, Simons R, Douthwaite ST, Lee MJ. Coronavirus disease 2019 aand Pneumocystis jirovecii pneumonia:A diagnostic dilemma in HIV. AIDS. 2020;34(8):1258-60. doi:10.1097\/qad.0000000000002571","DOI":"10.1097\/QAD.0000000000002571"},{"key":"144733","doi-asserted-by":"crossref","unstructured":"Menon AA, Berg DD, Brea EJ, Deutsch AJ, Kidia KK, Thurber EG, et al. ACase of COVID-19 aand Pneumocystis jirovecii Coinfection. Am J Respir Crit Care Med. 2020;202(1):136-8. doi:10.1164\/rccm.202003-0766le","DOI":"10.1164\/rccm.202003-0766LE"},{"key":"144734","doi-asserted-by":"crossref","unstructured":"Blaize M, Mayaux J, Luyt CE, Lampros A, Fekkar A. Covid-19-related respiratory failure and lymphopenia do not seem associated with pneumocystosis. Am J Respir Crit Care Med. 2020;202(12):1734-36. doi:10.1164\/rccm.202007-2938le","DOI":"10.1164\/rccm.202007-2938LE"},{"key":"144735","doi-asserted-by":"crossref","unstructured":"Morris A, Norris KA. Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev. 2012;25(2):297-317. doi:10.1128\/cmr.00013-12","DOI":"10.1128\/CMR.00013-12"},{"key":"144736","doi-asserted-by":"crossref","unstructured":"Shipley TW, Kling HM, Morris A, Patil S, Kristoff J, Guyach SE, et al. Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS. J Infect Dis. 2010;202(2):302-12. doi:10.1086\/653485","DOI":"10.1086\/653485"},{"key":"144737","doi-asserted-by":"crossref","unstructured":"Eddens T, Campfield BT, Serody K, Manni ML, Horne W, Elsegeiny W, et al. ANovel CD4+ T cell-dependent murine model of pneumocystis-driven asthma-like pathology. Am J Respir Crit Care Med. 2016;194(7):807-20. doi:10.1164\/rccm.201511-2205oc","DOI":"10.1164\/rccm.201511-2205OC"},{"key":"144738","doi-asserted-by":"crossref","unstructured":"Sepkowitz KA. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome:Who should receive prophylaxis?. Mayo Clin Proc. 1996;71(1):102-3. doi:10.4065\/71.1.102","DOI":"10.4065\/71.1.102"},{"key":"144739","doi-asserted-by":"crossref","unstructured":"Lu X, Sakthivel SK, Wang L, Lynch B, Dollard SM. Enhanced throughput of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) real-time RT-PCR panel by assay multiplexing and specimen pooling. J Virol Methods. 2021;293:114149. doi:10.1016\/j.jviromet.2021.114149","DOI":"10.1016\/j.jviromet.2021.114149"},{"key":"144740","doi-asserted-by":"crossref","unstructured":"Mondal S, Feirer N, Brockman M, Preston MA, Teter SJ, Ma D, et al. Adirect capture method for purification and detection of viral nucleic acid enables epidemiological surveillance of SARS-CoV-2. Sci Total Environ. 2021;795:148834. doi:10.1016\/j.scitotenv.2021.148834","DOI":"10.1016\/j.scitotenv.2021.148834"},{"key":"144741","doi-asserted-by":"crossref","unstructured":"Alsayed A, Al-Doori A, Al-Dulaimi A, Alnaseri A, Abuhashish J, Aliasin K, et al. iInfluences of bovine colostrum on nasal swab microbiome and viral upper respiratory tract infections-a case report. Respir Med Case Rep. 2020;31:101189. doi:10.1016\/j.rmcr.2020.101189","DOI":"10.1016\/j.rmcr.2020.101189"},{"key":"144742","doi-asserted-by":"crossref","unstructured":"Lim WS. Pneumonia-overview. Reference Module Biomed Sci. 2020;2:185-197.","DOI":"10.1016\/B978-0-12-801238-3.11636-8"},{"key":"144743","unstructured":"World Health Organization. Living guidance for clinical management of COVID-19:Living guidance. 2021."},{"key":"144744","doi-asserted-by":"crossref","unstructured":"Chew LC, Maceda-Galang LM, Tan YK, Chakraborty B, Thumboo J. Pneumocystis jirovecii pneumonia in patients with autoimmune disease on high-dose glucocorticoid. J Clin Rheumatol. 2015;21(2):72-5. doi:10.1097\/rhu.0000000000000215","DOI":"10.1097\/RHU.0000000000000215"},{"key":"144745","doi-asserted-by":"crossref","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 acases of 2019 novel coronavirus pneumonia in Wuhan, China:A descriptive study. Lancet. 2020;395(10223):507-13. doi:10.1016\/s0140-6736(20)30211-7","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"144746","doi-asserted-by":"crossref","unstructured":"Mang S, Kaddu-Mulindwa D, Metz C, Becker A, Seiler F, Smola S, et al. Pneumocystis jirovecii pneumonia and severe acute respiratory syndrome coronavirus 2 acoinfection in a patient with newly diagnosed HIV-1 infection. Clin Infect Dis. 2021;72(8):1487-9. doi:10.1093\/cid\/ciaa906","DOI":"10.1093\/cid\/ciaa906"},{"key":"144747","doi-asserted-by":"crossref","unstructured":"De Francesco MA, Alberici F, Bossini N, Scolari F, Pascucci F, Tomasoni G, et al. Pneumocystis jirevocii and SARS-CoV-2 aco-infection:A common feature in transplant recipients?. Vaccines (Basel). 2020;8(3):E544. doi:10.3390\/vaccines8030544","DOI":"10.3390\/vaccines8030544"},{"key":"144748","doi-asserted-by":"crossref","unstructured":"Permpalung N, Kittipibul V, Mekraksakit P, Rattanawong P, Nematollahi S, Zhang SX, et al. Acomprehensive evaluation of risk factors for Pneumocystis jirovecii pneumonia in adult solid organ transplant recipients:A systematic review and meta-analysis. Transplantation. 2021;105(10):2291-306. doi:10.1097\/tp.0000000000003576","DOI":"10.1097\/TP.0000000000003576"},{"key":"144749","doi-asserted-by":"crossref","unstructured":"Cai S, Sun W, Li M, Dong L. A complex COVID-19 acase with rheumatoid arthritis treated with tocilizumab. Clin Rheumatol. 2020;39(9):2797-802. doi:10.1007\/s10067-020-05234-w","DOI":"10.1007\/s10067-020-05234-w"},{"key":"144750","doi-asserted-by":"crossref","unstructured":"Hammarstr\u00f6m H, Grankvist A, Broman I, Kondori N, Wenner\u00e5s C, Gisslen M, et al. Serum-based diagnosis of pneumocystis pneumonia by detection of pneumocystis jirovecii DNA and 1,3-b-d-glucan in hiv-infected patients:A retrospective case control study. BMC Infect Dis. 2019;19(1):658. doi:10.1186\/s12879-019-4289-4","DOI":"10.1186\/s12879-019-4289-4"},{"key":"144751","doi-asserted-by":"crossref","unstructured":"Parker A, Shaw J, Karamchand S, Lahri S, Schrueder N, Chothia MY, et al. HIV and SARS-CoV-2 aco-infection:The diagnostic challenges of dual pandemics. S Afr Med J. 2020;110(6):473-5. doi:10.7196\/samj.2020.iav110i6.14825","DOI":"10.7196\/SAMJ.2020.v110i6.14825"},{"key":"144752","doi-asserted-by":"crossref","unstructured":"Hanfi SH, Lalani TK, Saghir A, McIntosh LJ, Lo HS, Kotecha HM. COVID-19 aand its mimics:What the radiologist needs to know. J Thorac Imaging. 2021;36(1):W1-10. doi:10.1097\/rti.0000000000000554","DOI":"10.1097\/RTI.0000000000000554"},{"key":"144753","doi-asserted-by":"crossref","unstructured":"Kanduc D, Shoenfeld Y. On the molecular determinants of the SARS-CoV-2 aattack. Clin Immunol. 2020;215:108426. doi:10.1016\/j.clim.2020.108426","DOI":"10.1016\/j.clim.2020.108426"},{"key":"144754","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693-704. doi:10.1056\/nejmoa2021436","DOI":"10.1056\/NEJMoa2021436"},{"key":"144755","doi-asserted-by":"crossref","unstructured":"Sun HB, Zhang YM, Huang LG, Lai QN, Mo Q, Ye XZ, et al. The changes of the peripheral CD4+lymphocytes and inflammatory cytokines in patients with COVID-19. PLoS One. 2020;15(9):0239532. doi:10.1371\/journal.pone.0239532","DOI":"10.1371\/journal.pone.0239532"},{"key":"144756","doi-asserted-by":"crossref","unstructured":"Nasim S, Kumar S, Azim D, Ashraf Z, Azeem Q. Corticosteroid use for 2019-nCoV infection:A double-edged sword. Infect Control Hosp Epidemiol. 2020;41(10):1244-5. doi:10.1017\/ice.2020.165","DOI":"10.1017\/ice.2020.165"},{"key":"144757","doi-asserted-by":"crossref","unstructured":"Patel R, Babady E, Theel ES, Storch GA, Pinsky BA, St G, et al. Report from the American society for microbiology COVID-19 ainternational summit, 23 March 2020:Value of diagnostic testing for SARS-CoV-2\/COVID-19. mBio. 2020;11(2):e00722-20. doi:10.1128\/mbio.00722-20","DOI":"10.1128\/mBio.00722-20"},{"key":"144758","doi-asserted-by":"crossref","unstructured":"Younes N, Al-Sadeq DW, Al-Jighefee H, Younes S, Al-Jamal O, Daas HI, et al. Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2. Viruses. 2020;12(6):E582. doi:10.3390\/v12060582","DOI":"10.3390\/v12060582"},{"key":"144759","doi-asserted-by":"crossref","unstructured":"Masur H, Brooks JT, Benson CA, Holmes KK, Pau AK, Kaplan JE, et al. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents:Updated guidelines from the centers for disease control and prevention, national institutes of health, and HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2014;58(9):1308-11. doi:10.1093\/cid\/ciu094","DOI":"10.1093\/cid\/ciu094"},{"key":"144760","doi-asserted-by":"crossref","unstructured":"Rubiano C, Tompkins K, Sellers SA, Bramson B, Eron J, Parr JB, et al. Pneumocystis and severe acute respiratory syndrome coronavirus 2 acoinfection:A case report and review of an emerging diagnostic dilemma. Open Forum Infect Dis. 2021;8(1):ofaa633. doi:10.1093\/ofid\/ofaa633","DOI":"10.1093\/ofid\/ofaa633"},{"key":"144761","doi-asserted-by":"crossref","unstructured":"Rodriguez-Morales AJ, Cardona-Ospina JA, Gutinaa-OsOcampo E, Villamizar-Pela R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19:A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. doi:10.1016\/j.tmaid.2020.101623","DOI":"10.1016\/j.tmaid.2020.101623"},{"key":"144762","doi-asserted-by":"crossref","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 ain china. N Engl J Med. 2020;382(18):1708-20.","DOI":"10.1056\/NEJMoa2002032"},{"key":"144763","doi-asserted-by":"crossref","unstructured":"White PL, Price JS, Backx M. Therapy and Management of Pneumocystis jirovecii Infection. J Fungi (Basel). 2018;4(4):E127. doi:10.3390\/jof4040127","DOI":"10.3390\/jof4040127"},{"key":"144764","doi-asserted-by":"crossref","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 anovel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"144765","doi-asserted-by":"crossref","unstructured":"Apfalter P, Assadian O, Blasi F, Boman J, Gaydos CA, Kundi M, et al. iReliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas:Results from a multicenter study applying standardized protocols. J Clin Microbiol. 2002;40(12):4428-34. doi:10.1128\/jcm.40.12.4428-4434.2002","DOI":"10.1128\/JCM.40.12.4428-4434.2002"},{"key":"144766","doi-asserted-by":"crossref","unstructured":"Desai H, Eschberger K, Wrona C, Grove L, Agrawal A, Grant B, et al. iBacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(3):303-9. doi:10.1513\/annalsats.201310-350oc","DOI":"10.1513\/AnnalsATS.201310-350OC"},{"key":"144767","doi-asserted-by":"crossref","unstructured":"Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359(22):2355-65. doi:10.1056\/nejmra0800353","DOI":"10.1056\/NEJMra0800353"},{"key":"144768","doi-asserted-by":"crossref","unstructured":"Murdoch DR. Molecular genetic methods in the diagnosis of lower respiratory tract infections. APMIS. 2004;112((11-12)):713-27. doi:10.1111\/j.1600-0463.2004.iaapm11211-1202.x","DOI":"10.1111\/j.1600-0463.2004.apm11211-1202.x"},{"key":"144769","doi-asserted-by":"crossref","unstructured":"Goldman DL, Chen Z, Shankar V, Tyberg M, Vicencio A, Burk R. Lower airway microbiota and mycobiota in children with severe asthma. J Allergy Clin Immunol. 2018;141(2):808-11e7. doi:10.1016\/j.jaci.2017.09.018","DOI":"10.1016\/j.jaci.2017.09.018"},{"key":"144770","doi-asserted-by":"crossref","unstructured":"Gingo MR, Lucht L, Daly KR, Djawe K, Palella FJ, Abraham AG, et al. Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia. J Acquir Immune Defic Syndr. 2011;57(3):190-6. doi:10.1097\/qai.0b013e3182167516","DOI":"10.1097\/QAI.0b013e3182167516"},{"key":"144771","doi-asserted-by":"crossref","unstructured":"Rayens E, Noble B, Vicencio A, Goldman DL, Bunyavanich S, Norris KA. Relationship of Pneumocystis antibody responses to paediatric asthma severity. BMJ Open Respir Res. 2021;8(1):000842. doi:10.1136\/bmjresp-2020-000842","DOI":"10.1136\/bmjresp-2020-000842"}],"container-title":["Biomolecules and Biomedicine"],"original-title":[],"link":[{"URL":"https:\/\/bjbms.org\/ojs\/index.php\/bjbms\/article\/download\/7335\/2507","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjbms.org\/ojs\/index.php\/bjbms\/article\/download\/7335\/2507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:05:01Z","timestamp":1795129501000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjbms.org\/ojs\/index.php\/bjbms\/article\/view\/7335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,9,16]]}},"URL":"https:\/\/doi.org\/10.17305\/bjbms.2022.7335","relation":{},"ISSN":["2831-090X","2831-0896"],"issn-type":[{"value":"2831-090X","type":"electronic"},{"value":"2831-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,16]]}}}